- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01085253
Nucleipark:High Field MR Imaging (7T and 3T) of the Brainstem, the Deep Nuclei and Their Connections in the Parkinsonian Syndromes. Applications to Prognosis, Pathophysiology and Improvement of Therapeutic Strategies (Nucleipark)
High Field MR Imaging (7T and 3T) of the Brainstem, the Deep Nuclei and Their Connections in the Parkinsonian Syndromes. Applications to Prognosis, Pathophysiology and Improvement of Therapeutic Strategies
To date except for the larger striato-pallidal complex, there are no reliable imaging markers of small deep nuclei. Major improvement of the spatial resolution resulting from the use of ultra-high field MRI systems offers new perspectives of imaging of these deep structures.
We will use the new contrast mechanisms available in data acquired with ultra-high field MR systems (7T) as well as the most recent high angular diffusion imaging techniques in order to characterize the cytoarchitectonics of the deep brain structures and brainstem lesions in parkinsonian syndromes (with special interest in substantia nigra (SN) pathology and nigro-striatal fiber pathways; subthalamic nucleus (STN), red nucleus (RN), oculomotor structures (involved in PSP); pedonculo-pontine nucleus (involved in gait and posture control disorders) and the locus sub-coeruleus area (implicated in sleep disorders) The optimized MR sequences at 7T will be adapted and validated at 3T (on a more clinically oriented MRI approach).
The clinical goal of the project (via the characterization of deep brain structures) is the detection of new neuroimaging markers of neuronal lesions in PD. These biomarkers will be used to create a diagnostic tool at early stage of the disease that could be correlated to clinical signs such as gait disorders and help to identify predictive factors. In addition, this could contribute to establish an adequate therapeutic strategy (as for example with deep brain stimulation).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Marie VIDAILHET, MD
- Phone Number: +33(0) 1 42162490
- Email: marie.vidailhet@psl.aphp.fr
Study Locations
-
-
-
Paris, France, 75013
- Recruiting
- Salpetriere Hospital
-
Contact:
- Marie VIDAILHET, MD
- Email: marie.vidailhet@psl.aphp.fr
-
Principal Investigator:
- Stephane LEHERICY, MD, PhD
-
Principal Investigator:
- Marie VIDAILHET, MD
-
Principal Investigator:
- Cyril POUPON
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- PD according to the UK brain bank diagnosis criteria
- PSP according to the NINDS diagnosis criteria
Exclusion Criteria:
- contra indication to MRI
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Parkinson
abnormalities of the brainstem and basal ganglia will be studied in relation with parkinsonism, gait and presence of RBD |
all patients and controls will be explored using a 3T and 7T MR imaging
|
PSP
supranuclear palsy patients study the abnormalities with the brainstem and basal ganglia and relation with the observed neurological signs (eye movements, balance, neuropsychological assessment and parkinsonism)
|
all patients and controls will be explored using a 3T and 7T MR imaging
|
controls
age matched controls
|
all patients and controls will be explored using a 3T and 7T MR imaging
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C09-15
- 2009-A00922-55 (Registry Identifier: IDRCB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MRI
-
Rennes University HospitalRecruiting
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
University of LiegeUnknown
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
PfizerCompletedMRI SedationUnited States, Japan
-
University of UtahWithdrawnMRI ScansUnited States
-
SpinTech, Inc.University of Iowa; University of Texas Southwestern Medical Center; Loma Linda... and other collaboratorsCompleted
Clinical Trials on 3T and 7T MR imaging
-
Cambridge University Hospitals NHS Foundation TrustNational Institute for Health Research, United Kingdom; Wolfson Brain Imaging...RecruitingCervical Spondylosis With Myelopathy | Degenerative Cervical MyelopathyUnited Kingdom
-
University of PennsylvaniaMedical University of South CarolinaRecruitingEpilepsy | Epilepsy, Temporal Lobe | Epilepsy IntractableUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingEpilepsy | Drug Resistant Epilepsy
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingMultiple SclerosisFrance
-
Nottingham University Hospitals NHS TrustRecruitingDementia (Diagnosis)United Kingdom
-
Cedars-Sinai Medical CenterRecruitingCoronary Artery Disease | CancerUnited States
-
Leiden University Medical CenterAlzheimer NederlandRecruitingCognitive Impairment | Mild Cognitive Impairment | Cerebral Small Vessel Diseases | Dementia, Vascular | Cognitive Decline | Dementia, MixedNetherlands
-
National Institute of Mental Health (NIMH)Recruiting
-
Centre Hospitalier St AnneUnknownPatients With Cognitive DisturbancesFrance
-
University Hospital Inselspital, BerneSwiss National Science FoundationRecruitingGlioma | Brain Tumor | IDH MutationSwitzerland